Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform?
1Department of Obstetrics and Gynecology, Istanbul University, School of Medicine, Turkey
*Corresponding Author(s): S. Topuz E-mail: samettopuz@yahoo.com
Conservative management of patients with endometrial cancer who desire fertility is becoming widespread in certain circumstances. A 36-year-old women desiring fertility with early-stage endometroid type adenocarcinoma of the endometrium was treated with 160 mg/d megestrol acetate for six months. After confirmation of a normal endometrial biopsy she became pregnant spontaneously. Following an uneventful pregnancy a healthy baby at term was delivered by cesarean section. Definitive surgery was performed. The risks and benefits of this thereupeutic approach are discussed and informing style of the patients emphasized.
Endometrial carcinoma, Conservative management, Patient information
S. Topuz,I. Kaleliog˘lu,C. Iyibozkurt,B. Ergun. Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform?. European Journal of Gynaecological Oncology. 2008. 29(6);661-663.
[1] Hoskins W.J., Perez C.A.,Young R.C.: “Principals and Practice of Gynecologic Oncology”. 3rd edition, Philadelphia, PA, Lippincott Williams and Wilkins, 2000, 981.
[2] Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: “Surgical pathologic spread patterns of endometrial cancer (a Gynecologic Oncology Group study)”. Cancer 1987, 60, 2035.
[3] Crissman J.D., Azoury R.S., Barnes A.E., Schellhas H.F.: “Endometrial cancer in women 40 years of age or younger”. Obstet. Gynecol., 1981, 57, 699.
[4] Vasen H.F.A., Wijnen J.T., Menko F.H., Kleibeuker J.H., Taal B.G., Griffioen G. et al.: “Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis”. Gastroenterol., 1996, 110, 1020.
[5] Powell J.L., Hill K.A., Shiro B.C., Diehl S.J., Gajewski W.H.: “Preoperative serum CA-125 levels in treating endometrial cancer”. J. Reprod. Med., 2005, 50, 585.
[6] Bettocchi S., Ceci O., Vicino M., Marello F., Impedovo L., Selvaggi L.: “Diagnostic inadequacy of dilatation and curettage”. Fertil. Steril., 2001, 75, 803.
[7] Stock R.G., Kanbour A.: “Prehysterectomy curettage”. Obstet. Gynecol., 1975, 45, 537.
[8] Saez F., Urresola A., Larena J.A., Martin J.I., Pijuan J.I., Schneider J., Ibanez E.: “Endometrial carcinoma: assessment of myometrial invasion with plain and gadolinum-enhanced MR imaging”. J. Magn. Reson. Imaging., 2000, 12, 460.
[9] Benshushan A.: “Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 117, 132.
[10] Benshushan A., Paltiel O., Brzezinski A., Tanos V., Barchana, Shoshani O. et al.: “Ovulation induction and risk of endometrial cancer: a pilot study”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 9, 53.
Top